{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:26:30Z","timestamp":1790767590630,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS078375"],"award-info":[{"award-number":["R01NS078375"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS102451"],"award-info":[{"award-number":["R01NS102451"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS099977"],"award-info":[{"award-number":["R21NS099977"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA027079"],"award-info":[{"award-number":["R01AA027079"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41593-021-00827-3","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T12:02:36Z","timestamp":1617278556000},"page":"930-940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":195,"title":["Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit"],"prefix":"10.1038","volume":"24","author":[{"given":"Meaghan","family":"Van Alstyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7925-4609","authenticated-orcid":false,"given":"Ivan","family":"Tattoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Delestr\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yocelyn","family":"Recinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamya S.","family":"Shihabuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4610-2016","authenticated-orcid":false,"given":"George Z.","family":"Mentis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-5628","authenticated-orcid":false,"given":"Livio","family":"Pellizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AHM Burghes","year":"2009","unstructured":"Burghes, A. H. M. & Beattie, C. E. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci. 10, 597\u2013609 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"827_CR2","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","volume":"35","author":"S Tisdale","year":"2015","unstructured":"Tisdale, S. & Pellizzoni, L. Disease mechanisms and therapeutic approaches in spinal muscular atrophy. J. Neurosci. 35, 8691\u20138700 (2015).","journal-title":"J. Neurosci."},{"key":"827_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165 (1995).","journal-title":"Cell"},{"key":"827_CR4","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA 96, 6307\u20136311 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"827_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature10485","volume":"478","author":"Y Hua","year":"2011","unstructured":"Hua, Y. et al. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478, 123\u2013126 (2011).","journal-title":"Nature"},{"key":"827_CR6","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","volume":"21","author":"PN Porensky","year":"2012","unstructured":"Porensky, P. N. et al. A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum. Mol. Genet. 21, 1625\u20131638 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"827_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1126\/science.1250127","volume":"345","author":"NA Naryshkin","year":"2014","unstructured":"Naryshkin, N. A. et al. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science 345, 688\u2013693 (2014).","journal-title":"Science"},{"key":"827_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nchembio.1837","volume":"11","author":"J Palacino","year":"2015","unstructured":"Palacino, J. et al. SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat. Chem. Biol. 11, 511\u2013517 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust, K. D. et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotechnol. 28, 271\u2013274 (2010).","journal-title":"Nat. Biotechnol."},{"key":"827_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1172\/JCI41615","volume":"120","author":"MA Passini","year":"2010","unstructured":"Passini, M. A. et al. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. J. Clin. Invest. 120, 1253\u20131264 (2010).","journal-title":"J. Clin. Invest."},{"key":"827_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/hmg\/ddq514","volume":"20","author":"E Dominguez","year":"2011","unstructured":"Dominguez, E. et al. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum. Mol. Genet. 20, 681\u2013693 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"827_CR12","doi-asserted-by":"publisher","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","volume":"2","author":"CF Valori","year":"2010","unstructured":"Valori, C. F. et al. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci. Transl. Med. 2, 35ra42 (2010).","journal-title":"Sci. Transl. Med."},{"key":"827_CR13","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel, R. S. et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723\u20131732 (2017).","journal-title":"N. Engl. J. Med."},{"key":"827_CR14","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel, R. S. et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 388, 3017\u20133026 (2016).","journal-title":"Lancet"},{"key":"827_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri, E. et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N. Engl. J. Med. 378, 625\u2013635 (2018).","journal-title":"N. Engl. J. Med."},{"key":"827_CR16","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"827_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ppul.24203","volume":"54","author":"S Al-Zaidy","year":"2019","unstructured":"Al-Zaidy, S. et al. Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy. Pediatr. Pulmonol. 54, 179\u2013185 (2019).","journal-title":"Pediatr. Pulmonol."},{"key":"827_CR18","doi-asserted-by":"crossref","unstructured":"Dhillon, S. Risdiplam: first approval. Drugs 80, 1853\u20131858 (2020).","DOI":"10.1007\/s40265-020-01410-z"},{"key":"827_CR19","doi-asserted-by":"publisher","unstructured":"Mercuri, E., Pera, M. C., Scoto, M., Finkel, R. & Muntoni, F. Spinal muscular atrophy\u2014insights and challenges in the treatment era. Nat. Rev. Neurol. https:\/\/doi.org\/10.1038\/s41582-020-00413-4 (2020).","DOI":"10.1038\/s41582-020-00413-4"},{"key":"827_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer, C. et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum. Gene Ther. 29, 285\u2013298 (2018).","journal-title":"Hum. Gene Ther."},{"key":"827_CR21","unstructured":"National Library of Medicine. Study of intrathecal administration of onasemnogene abeparvovec-xioi for spinal muscular atrophy (STRONG). ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03381729 (2017)."},{"key":"827_CR22","unstructured":"European Medicines Agency. Zolgensma: European public assessment report. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/zolgensma-epar-public-assessment-report_en.pdf (2020)."},{"key":"827_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/hum.2014.011","volume":"25","author":"MA Passini","year":"2014","unstructured":"Passini, M. A. et al. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy. Hum. Gene Ther. 25, 619\u2013630 (2014).","journal-title":"Hum. Gene Ther."},{"key":"827_CR24","unstructured":"Gray, S. J. & Samulski, R. Vector design and considerations for CNS applications. in Gene Vector Design and Application to Treat Nervous System Disorders (ed. Glorioso. J.) 7\u201315 (Society for Neuroscience, 2011)."},{"key":"827_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/cne.1100","volume":"432","author":"MD Taylor","year":"2001","unstructured":"Taylor, M. D. et al. Postnatal regulation of limb proprioception by muscle-derived neurotrophin-3. J. Comp. Neurol. 432, 244\u2013258 (2001).","journal-title":"J. Comp. Neurol."},{"key":"827_CR26","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1016\/j.celrep.2019.11.058","volume":"29","author":"CM Simon","year":"2019","unstructured":"Simon, C. M. et al. Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy. Cell Rep. 29, 3885\u20133901 (2019).","journal-title":"Cell Rep."},{"key":"827_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","volume":"69","author":"GZ Mentis","year":"2011","unstructured":"Mentis, G. Z. et al. Early functional impairment of sensorimotor connectivity in a mouse model of spinal muscular atrophy. Neuron 69, 453\u2013467 (2011).","journal-title":"Neuron"},{"key":"827_CR28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nn.4561","volume":"20","author":"EV Fletcher","year":"2017","unstructured":"Fletcher, E. V. et al. Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy. Nat. Neurosci. 20, 905\u2013916 (2017).","journal-title":"Nat. Neurosci."},{"key":"827_CR29","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1016\/j.celrep.2017.12.003","volume":"21","author":"CM Simon","year":"2017","unstructured":"Simon, C. M. et al. Converging mechanisms of p53 activation drive motor neuron degeneration in spinal muscular atrophy. Cell Rep. 21, 3767\u20133780 (2017).","journal-title":"Cell Rep."},{"key":"827_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semcdb.2014.04.026","volume":"32","author":"DK Li","year":"2014","unstructured":"Li, D. K., Tisdale, S., Lotti, F. & Pellizzoni, L. SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease. Semin. Cell Dev. Biol. 32, 22\u201329 (2014).","journal-title":"Semin. Cell Dev. Biol."},{"key":"827_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/MCB.06077-11","volume":"32","author":"M Ruggiu","year":"2012","unstructured":"Ruggiu, M. et al. A role for SMN exon 7 splicing in the selective vulnerability of motor neurons in spinal muscular atrophy. Mol. Cell. Biol. 32, 126\u2013138 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"827_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1101\/gad.316059.118","volume":"32","author":"M Van Alstyne","year":"2018","unstructured":"Van Alstyne, M. et al. Dysregulation of Mdm2 and Mdm4 alternative splicing underlies motor neuron death in spinal muscular atrophy. Genes Dev. 32, 1045\u20131059 (2018).","journal-title":"Genes Dev."},{"key":"827_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1101\/gad.2004811","volume":"25","author":"AL Saltzman","year":"2011","unstructured":"Saltzman, A. L., Pan, Q. & Blencowe, B. J. Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev. 25, 373\u2013384 (2011).","journal-title":"Genes Dev."},{"key":"827_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molimm.2018.06.264","volume":"102","author":"AJ Tenner","year":"2018","unstructured":"Tenner, A. J., Stevens, B. & Woodruff, T. M. New tricks for an ancient system: physiological and pathological roles of complement in the CNS. Mol. Immunol. 102, 3\u201313 (2018).","journal-title":"Mol. Immunol."},{"key":"827_CR35","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1016\/j.celrep.2019.11.013","volume":"29","author":"A Vukojicic","year":"2019","unstructured":"Vukojicic, A. et al. The classical complement pathway mediates microglia-dependent remodeling of spinal motor circuits during development and in SMA. Cell Rep. 29, 3087\u20133100 (2019).","journal-title":"Cell Rep."},{"key":"827_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","volume":"64","author":"KM Lucin","year":"2009","unstructured":"Lucin, K. M. & Wyss-Coray, T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64, 110\u2013122 (2009).","journal-title":"Neuron"},{"key":"827_CR37","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/hmg\/ddt477","volume":"23","author":"JN Sleigh","year":"2014","unstructured":"Sleigh, J. N. et al. Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy. Hum. Mol. Genet. 23, 855\u2013869 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"827_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuron.2019.03.014","volume":"102","author":"JK Nussbacher","year":"2019","unstructured":"Nussbacher, J. K., Tabet, R., Yeo, G. W. & Lagier-Tourenne, C. Disruption of RNA metabolism in neurological diseases and emerging therapeutic interventions. Neuron 102, 294\u2013320 (2019).","journal-title":"Neuron"},{"key":"827_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","volume":"9","author":"UR Monani","year":"2000","unstructured":"Monani, U. R. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn\u2212\/\u2212 mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333\u2013339 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"827_CR40","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/hmg\/ddm379","volume":"17","author":"TO Gavrilina","year":"2008","unstructured":"Gavrilina, T. O. et al. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum. Mol. Genet. 17, 1063\u20131075 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"827_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ng0598-63","volume":"19","author":"CL Lorson","year":"1998","unstructured":"Lorson, C. L. et al. SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat. Genet. 19, 63\u201366 (1998).","journal-title":"Nat. Genet."},{"key":"827_CR42","doi-asserted-by":"publisher","first-page":"11167","DOI":"10.1073\/pnas.96.20.11167","volume":"96","author":"L Pellizzoni","year":"1999","unstructured":"Pellizzoni, L., Charroux, B. & Dreyfuss, G. SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc. Natl Acad. Sci. USA 96, 11167\u201311172 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"827_CR43","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1093\/hmg\/8.13.2351","volume":"8","author":"D B\u00fchler","year":"1999","unstructured":"B\u00fchler, D., Raker, V., L\u00fchrmann, R. & Fischer, U. Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy. Hum. Mol. Genet. 8, 2351\u20132357 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"827_CR44","unstructured":"U.S. Food and Drug Administration. AveXis. Zolgensma (onasemnogene abeparvovec-xioi) package insert. https:\/\/www.fda.gov\/vaccines-blood-biologics\/zolgensma (2019)."},{"key":"827_CR45","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","volume":"26","author":"J Hordeaux","year":"2018","unstructured":"Hordeaux, J. et al. The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice. Mol. Ther. 26, 664\u2013668 (2018).","journal-title":"Mol. Ther."},{"key":"827_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnana.2014.00042","volume":"8","author":"DJ Schuster","year":"2014","unstructured":"Schuster, D. J. et al. Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse. Front. Neuroanat. 8, 42 (2014).","journal-title":"Front. Neuroanat."},{"key":"827_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1101\/gr.7.4.339","volume":"7","author":"CJ DiDonato","year":"1997","unstructured":"DiDonato, C. J. et al. Cloning, characterization and copy number of the murine survival motor neuron gene homolog of the spinal muscular atrophy-determining gene. Genome Res. 7, 339\u2013352 (1997).","journal-title":"Genome Res."},{"key":"827_CR48","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/dvdy.21642","volume":"237","author":"MA Lorson","year":"2008","unstructured":"Lorson, M. A., Spate, L. D., Prather, R. S. & Lorson, C. L. Identification and characterization of the porcine (Sus scrofa) survival motor neuron (SMN1) gene: an animal model for therapeutic studies. Dev. Dyn. 237, 2268\u20132278 (2008).","journal-title":"Dev. Dyn."},{"key":"827_CR49","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1093\/nar\/gkt216","volume":"41","author":"J Wu","year":"2013","unstructured":"Wu, J., Anczuk\u00f3w, O., Krainer, A. R., Zhang, M. Q. & Zhang, C. OLego: fast and sensitive mapping of spliced mRNA-seq reads using small seeds. Nucleic Acids Res. 41, 5149\u20135163 (2013).","journal-title":"Nucleic Acids Res."},{"key":"827_CR50","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1073\/pnas.1502849112","volume":"112","author":"Q Yan","year":"2015","unstructured":"Yan, Q. et al. Systematic discovery of regulated and conserved alternative exons in the mammalian brain reveals NMD modulating chromatin regulators. Proc. Natl Acad. Sci. USA 112, 3445\u20133450 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"827_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate\u2014a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"827_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., Mccarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"827_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-021-00827-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-021-00827-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-021-00827-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:08:05Z","timestamp":1787054885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-021-00827-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1038\/s41593-021-00827-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739855545.793584392","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.739855545.793584550","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"4 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}